| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/09/1997 | WO1997000691A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | WO1997000685A1 Use of substituted pentose or hexose derivates in the treatment of aids and aids related neoplastic disorders |
| 01/09/1997 | WO1996040040A3 Thrombin receptor homolog |
| 01/09/1997 | WO1996039511A3 A c5a-like seven transmembrane receptor |
| 01/09/1997 | WO1996032137A3 Methods of inducing immune tolerance using immunotoxins |
| 01/09/1997 | CA2225401A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | CA2225318A1 Diagnostic test for equine arteritis virus mediated disease |
| 01/09/1997 | CA2224797A1 Immortalized epithelial tumor cell |
| 01/09/1997 | CA2222455A1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 01/08/1997 | EP0752473A2 Cloning and characterization of H. pylori flbA gene: production of flagella-free strains |
| 01/08/1997 | EP0752248A1 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 01/08/1997 | EP0752104A1 Differential expansion of fetal stem cells in the maternal circulation for use in prenatal genetic analysis |
| 01/08/1997 | EP0752008A1 Dna mutagenesis by random fragmentation and reassembly |
| 01/08/1997 | EP0752005A1 Compacted nucleic acids and their delivery to cells |
| 01/08/1997 | EP0752000A1 Packaging-deficient lentiviruses |
| 01/08/1997 | EP0751992A1 Vascular endothelial growth factor 2 |
| 01/08/1997 | EP0751987A1 Genetically modified cells for use in transplantation |
| 01/08/1997 | EP0751962A1 Methods and compositions for inhibiting cd14 mediated cell activation |
| 01/08/1997 | EP0751960A1 Synthetic inverso or retro-inverso t-cell epitopes |
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 01/08/1997 | EP0751956A1 $i(PASTEURELLACEAE) ANTIGENS AND RELATED VACCINES |
| 01/08/1997 | EP0751788A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug |
| 01/08/1997 | EP0751786A1 Urease-based vaccine and treatment for helicobacter infection |
| 01/08/1997 | EP0751785A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 01/08/1997 | EP0751782A1 Methods for altering fertility |
| 01/08/1997 | EP0751781A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40 |
| 01/08/1997 | EP0751780A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
| 01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/08/1997 | EP0580672B1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN |
| 01/08/1997 | EP0471726B1 Acellular vaccine |
| 01/08/1997 | EP0386166B1 PROTAMINE-REACTIVE IgM ANTIBODIES |
| 01/08/1997 | EP0273928B1 A PROTEIN ACTIVE IN HUMORAL HYPERCALCEMIA OF MALIGNANCY-PTHrP |
| 01/08/1997 | CN1139703A Polypeptide for expressing virus of pig reproduction and respiration syndrome in same cell |
| 01/07/1997 | US5591828 Genetic engineering |
| 01/07/1997 | US5591825 Dna and transducers |
| 01/07/1997 | US5591823 Expression of specific immunogens using viral antigens |
| 01/07/1997 | US5591645 Solid phase chromatographic immunoassay |
| 01/07/1997 | US5591638 Method for the transformation of cells, particularly eukaryotes by a DNA originating from viruses of hepatitis, more particularly from virus of B viral hepatitis, and preparations containing the expression products of said DNAs |
| 01/07/1997 | US5591632 Recombinant BCG |
| 01/07/1997 | US5591629 Monoclonal antibodies which promote central nervous system remyelination |
| 01/07/1997 | US5591624 Retroviral packaging cell lines |
| 01/07/1997 | US5591602 Nucleic acid encoding opioid receptor |
| 01/07/1997 | US5591593 Peptide sequence which binds to a mucin expressed by an epithelial tumor |
| 01/07/1997 | US5591574 Probes, diagnostic method and immunization method based on papillomavirus types HPV 49 and HPV 50 |
| 01/07/1997 | US5591572 Aids, hiv |
| 01/07/1997 | US5591441 Composition for nonspecific cellular immune stimulation |
| 01/07/1997 | US5591440 Hepatitis B Virus mutants, reagents and methods for detection |
| 01/07/1997 | US5591439 Treatment of herpes infections |
| 01/07/1997 | US5591434 DNA sequence encoding surface protein of cryptosporidium parvum |
| 01/07/1997 | US5591433 Oral administration of immunologically active biomolecules and other therapeutic proteins |
| 01/07/1997 | CA1338828C Bispecific antibody determinants |
| 01/03/1997 | WO1997000445A1 Process for producing gm2 specific antibodies |
| 01/03/1997 | WO1997000322A1 Immunogenic construct, process for its preparation and use as a vaccine |
| 01/03/1997 | WO1997000321A1 Immune response modulators and uses therefor |
| 01/03/1997 | WO1997000088A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | WO1997000086A1 Immunogenic preparation and method for improving the productivity of ruminant animals |
| 01/03/1997 | WO1997000085A1 Gene therapy of solid tumors with interferons alone or with other immuno-effector proteins |
| 01/03/1997 | WO1997000067A1 Mycobacterium tuberculosis dna sequences encoding immunostimulatory peptides |
| 01/03/1997 | CA2224697A1 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | CA2224645A1 Immunogenic construct, process for its preparation and use as a vaccine |
| 01/02/1997 | EP0751221A1 Recombinant mistletoe lectin (rML) |
| 01/02/1997 | EP0751147A1 Toxoplasma gondii antigen, its production and use |
| 01/02/1997 | EP0751144A1 Novel anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy |
| 01/02/1997 | EP0750907A2 Stable macrolide and macrolide vaccine compositions |
| 01/02/1997 | EP0750679A1 Isolated, tyrosinase derived peptides and uses thereof |
| 01/02/1997 | EP0750670A1 Compositions useful in controlling marek's disease |
| 01/02/1997 | EP0750669A1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM |
| 01/02/1997 | EP0750666A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
| 01/02/1997 | EP0750644A1 Water insoluble cross-linked polycarbonic acid compositions |
| 01/02/1997 | EP0750637A1 Dna encoding cai resistance proteins and uses thereof |
| 01/02/1997 | EP0750636A1 Methods to diagnose and treat hiv-1 infection |
| 01/02/1997 | EP0750626A1 Corpuscles of stannius protein, stanniocalcin |
| 01/02/1997 | EP0750514A1 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins |
| 01/02/1997 | EP0750513A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 01/02/1997 | EP0750510A1 Skin treatment composition |
| 01/02/1997 | EP0750509A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 01/02/1997 | EP0750508A1 RETROPEPTIDES, ANTIBODIES THERETO, AND USES THEREOF FOR VACCINATION AND $i(IN VITRO) DIAGNOSIS |
| 01/02/1997 | EP0750505A1 Immunotherapy of cancer with allogeneic lymphocytes |
| 01/02/1997 | EP0750498A1 Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne |
| 01/02/1997 | EP0750457A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells |
| 01/02/1997 | EP0564461B1 The use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 01/02/1997 | EP0538341B1 Ehv-4 glycoprotein vaccine |
| 01/02/1997 | EP0532746B1 Assay for non-a non-b hepatitis |
| 01/02/1997 | DE19526386C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them |
| 01/01/1997 | CN1139115A Anti-aV-integrin monoclonal antibody |
| 12/31/1996 | US5589585 DNA fragments, probes and amplification primers of the 65 kD antigen of mycobacteria |
| 12/31/1996 | US5589582 Polynucleotides en coding porcine cytokines |
| 12/31/1996 | US5589579 Gene sequence and probe for a marker of non-small cell lung carinoma |
| 12/31/1996 | US5589463 Oral delivery of biologically active substances bound to vitamin B12 |
| 12/31/1996 | US5589384 Formation of pentamer complex and binding to gangliosides and hinges of glycineproline and antigens or epitopes |
| 12/31/1996 | US5589380 Isolated DNA molecule encoding SHET1 of Shigella flexneri 2a and mutant Shigella flexneri 2a |
| 12/31/1996 | US5589374 Diabetogene rad: a type II diabetes specific gene |
| 12/31/1996 | US5589359 Chimeric proteins |
| 12/31/1996 | US5589358 Ileal bile acid transporter compositions and methods |
| 12/31/1996 | US5589343 Antibodies which bind to molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by P. falciparum in hepatocytes |
| 12/31/1996 | US5589340 Process and primers for identifying nucleic acids encoding A-lineage conotoxin peptides |
| 12/31/1996 | US5589334 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor which is processed to an antigen presented by HLA-B44, and uses thereof |
| 12/31/1996 | US5589175 Vaccines against aids |
| 12/31/1996 | US5589174 Anti-human influenza virus antibody |
| 12/31/1996 | US5589173 Anticoagulants |